<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03328871</url>
  </required_header>
  <id_info>
    <org_study_id>LXiao FirstJinanU</org_study_id>
    <nct_id>NCT03328871</nct_id>
  </id_info>
  <brief_title>The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.</brief_title>
  <official_title>The Combination Therapy of Fractional Laser and Platelet-Rich Plasma Injection Compared With Nanofat Grafting and Platelet-Rich Plasma Synergy in Treating Striae Gravidarum.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Jinan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Science and Technology Program of Guangzhou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital of Jinan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays, multiple treatment modalities have been applied clinically to treat striae
      gravidarum, such as laser therapy, microdermabrasion, platelet-rich plasma injection(PRP),
      etc. To some extent, these treatments can improve striae gravidarum. In this clinical trial,
      the investigators are going to treat striae gravidarum by using two different kinds of
      combination therapies. One is fractional laser and PRP injection synergy, and the other one
      is treated by nanofat grafting with PRP injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will pick out two areas of most severe striae gravidarum on a participant's
      abdomen. One of the areas will be treated by fractional laser once every three months for 2
      times combined with PRP injection once a month for 6 times. Another area will be treated by
      nanofat grafting once every three months for 2 times and PRP therapy once a month for 6
      times. The participants were asked to come back 1、3、6、9 months after treatment for further
      follow-up.

      Before and after the treatment, the striae gravidarum will be assessed subjectively by
      satisfaction assessment, dermatoscope and ultrasound, and objectively by immunohistochemical
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 14, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immunohistochemical analysis</measure>
    <time_frame>Baseline and 15 months.</time_frame>
    <description>The tissue extracted will be taken for immunohistochemical analysis to observe the change of epidermal and dermal thickness, and the distribution and amount of elastic fiber and collagen fiber,etc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dermatoscope</measure>
    <time_frame>Baseline and at 3,6,9,12,15 months after the treatments.</time_frame>
    <description>The striae gravidarum will be assessed by dermatoscope to observe the pigmentation condition of striae after the application of laser or nanofat grafting with PRP injection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound</measure>
    <time_frame>Baseline and at 3,6,9,12,15 months after the treatments.</time_frame>
    <description>The striae gravidarum will be assessed by ultrasound in order to observe the change of dermal thickness of striae after the application of laser or nanofat grafting with PRP injection.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Satisfaction assessments</measure>
    <time_frame>After every sessions of treatments, and at 6,9,12,15 months.</time_frame>
    <description>The participants, investigators and physicians will fill in a satisfaction assessment about any complication during the treatments.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Treatments of Striae Gravidarum</condition>
  <arm_group>
    <arm_group_label>Fractional CO2 Laser and PRP injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One of the striae gravidarum areas will be treated by fractional laser once every three months for 2 times combined with PRP injection once a month for 6 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nanofat grafting and PRP injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Another area will be treated by nanofat grafting once every three months for 2 times and PRP therapy once a month for 6 times.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fractional CO2 Laser</intervention_name>
    <description>Fractional Carbon Dioxide Laser will be treated once every three months for 2 times.</description>
    <arm_group_label>Fractional CO2 Laser and PRP injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nanofat grafting</intervention_name>
    <description>Nanofat grafting will be applied once every three months for 2 times.</description>
    <arm_group_label>Nanofat grafting and PRP injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet-rich plasma (PRP) Injection</intervention_name>
    <description>PRP Injection will be applied once a month for 6 times.</description>
    <arm_group_label>Fractional CO2 Laser and PRP injection</arm_group_label>
    <arm_group_label>Nanofat grafting and PRP injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The striae gravidarum was appeared within 3 years

          -  Age ≤ 35 years old

          -  Not in lactation

          -  Not pregnancy within one year

        Exclusion Criteria:

          -  Skin allergy

          -  Skin inflammation or wound

          -  Platelet dysfunction syndrome

          -  Take anticoagulant drugs

          -  Acute or chronic infection

          -  Chronic liver disease

          -  Photodermatosis

          -  Active vitiligo, psoriasis, systemic lupus erythematosus

          -  Other clinical trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Affiliated Hospital of Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>500011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://pubmed.cn/22182435</url>
    <description>Treatment of traumatic scars using fat grafts mixed with platelet-rich plasma, and resurfacing of skin with the 1540 nm nonablative laser.</description>
  </link>
  <link>
    <url>http://pubmed.cn/26171752</url>
    <description>Platelet-Rich Plasma with Basic Fibroblast Growth Factor for Treatment of Wrinkles and Depressed Areas of the Skin.</description>
  </link>
  <link>
    <url>http://pubmed.cn/24641609</url>
    <description>Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles.</description>
  </link>
  <link>
    <url>http://pubmed.cn/22994672</url>
    <description>Efficacy of intradermal radiofrequency combined with autologous platelet-rich plasma in striae distensae: a pilot study.</description>
  </link>
  <link>
    <url>http://pubmed.cn/23783059</url>
    <description>Nanofat grafting: basic research and clinical applications.</description>
  </link>
  <reference>
    <citation>Cervelli V, Nicoli F, Spallone D, Verardi S, Sorge R, Nicoli M, Balzani A. Treatment of traumatic scars using fat grafts mixed with platelet-rich plasma, and resurfacing of skin with the 1540 nm nonablative laser. Clin Exp Dermatol. 2012 Jan;37(1):55-61. doi: 10.1111/j.1365-2230.2011.04199.x.</citation>
    <PMID>22182435</PMID>
  </reference>
  <reference>
    <citation>Kamakura T, Kataoka J, Maeda K, Teramachi H, Mihara H, Miyata K, Ooi K, Sasaki N, Kobayashi M, Ito K. Platelet-Rich Plasma with Basic Fibroblast Growth Factor for Treatment of Wrinkles and Depressed Areas of the Skin. Plast Reconstr Surg. 2015 Nov;136(5):931-9. doi: 10.1097/PRS.0000000000001705.</citation>
    <PMID>26171752</PMID>
  </reference>
  <reference>
    <citation>Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles. J Cosmet Dermatol. 2014 Mar;13(1):72-8. doi: 10.1111/jocd.12072.</citation>
    <PMID>24641609</PMID>
  </reference>
  <reference>
    <citation>Kim IS, Park KY, Kim BJ, Kim MN, Kim CW, Kim SE. Efficacy of intradermal radiofrequency combined with autologous platelet-rich plasma in striae distensae: a pilot study. Int J Dermatol. 2012 Oct;51(10):1253-8. doi: 10.1111/j.1365-4632.2012.05530.x.</citation>
    <PMID>22994672</PMID>
  </reference>
  <reference>
    <citation>Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013 Oct;132(4):1017-26. doi: 10.1097/PRS.0b013e31829fe1b0.</citation>
    <PMID>23783059</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2017</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Jinan University</investigator_affiliation>
    <investigator_full_name>Li-Ling Xiao</investigator_full_name>
    <investigator_title>Associate Chief of Department of Plastic Surgery,The First Affiliated Hospital of Jinan University, Guangzhou</investigator_title>
  </responsible_party>
  <keyword>Striae Gravidarum</keyword>
  <keyword>Fractional Laser</keyword>
  <keyword>Platelet-Rich Plasma (PRP)</keyword>
  <keyword>Nanofat Graft</keyword>
  <keyword>Combination Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Striae Distensae</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

